WOLFF ANDREW A
Related Filers (2)
Ownership (21)
4
Thursday, 3/2/2017
CYTOKINETICS INC: Statement of changes in beneficial ownership of securities
4
Thursday, 2/25/2016
CYTOKINETICS INC: Statement of changes in beneficial ownership of securities
4
Friday, 3/13/2015
CYTOKINETICS INC: Statement of changes in beneficial ownership of securities
4
Monday, 3/2/2015
CYTOKINETICS INC: Statement of changes in beneficial ownership of securities
4
Thursday, 9/5/2013
CYTOKINETICS INC: Statement of changes in beneficial ownership of securities
4
Thursday, 3/7/2013
CYTOKINETICS INC: Statement of changes in beneficial ownership of securities
4
Wednesday, 9/5/2012
CYTOKINETICS INC: Statement of changes in beneficial ownership of securities
4
Wednesday, 3/7/2012
CYTOKINETICS INC: Statement of changes in beneficial ownership of securities
4
Monday, 11/21/2011
CYTOKINETICS INC: Statement of changes in beneficial ownership of securities
4
Tuesday, 3/1/2011
CYTOKINETICS INC: Statement of changes in beneficial ownership of securities
4
Friday, 2/26/2010
CYTOKINETICS INC: Statement of changes in beneficial ownership of securities
4
Monday, 3/2/2009
CYTOKINETICS INC: Statement of changes in beneficial ownership of securities
4
Tuesday, 3/4/2008
CYTOKINETICS INC: Statement of changes in beneficial ownership of securities
4
Friday, 3/16/2007
CYTOKINETICS INC: Statement of changes in beneficial ownership of securities
4
Friday, 3/3/2006
CYTOKINETICS INC: Statement of changes in beneficial ownership of securities
4
Wednesday, 4/13/2005
CYTOKINETICS INC: Statement of changes in beneficial ownership of securities
4
Thursday, 10/21/2004
CYTOKINETICS INC: Statement of changes in beneficial ownership of securities
3
Monday, 9/20/2004
CYTOKINETICS INC: Initial statement of beneficial ownership of securities
3
Monday, 9/20/2004
CYTOKINETICS INC: Initial statement of beneficial ownership of securities
4
Thursday, 4/8/2004
CV THERAPEUTICS INC: Statement of changes in beneficial ownership of securities
4
Friday, 12/12/2003
CV THERAPEUTICS INC: Statement of changes in beneficial ownership of securities